Massive high-concentration long-acting insulin overdose with suicidal intent - a case report.
Popiołek Alicja A, Bielun Kinga K, Niemczuk Ewa E, Pulkowski Grzegorz G
Intentional insulin overdose has been reported both in individuals with diabetes and in non-diabetic individuals who have access to insulin. As diabetology and insulin therapy continue to evolve, the pharmacodynamic profiles of insulin preparations have also changed, which may influence the clinical course of insulin overdose and poisoning. This case illustrates the prolonged metabolic consequences of a massive overdose of insulin glargine U300 in a non-diabetic individual (a total of 3,150 units administered subcutaneously). Despite its ultra-long-acting formulation, the duration of clinically significant hypoglycemia substantially exceeded that expected based on the pharmacokinetic profile, necessitating continuous intravenous glucose administration for 11 days. Throughout her hospital stay, the patient also required supplementation with phosphate, magnesium, and potassium to correct persistent electrolyte disturbances. This case highlights the importance of prolonged monitoring, aggressive glucose replacement, correction of associated electrolyte abnormalities, and multidisciplinary psychiatric management.